Discovery Programme Award supports established researchers pursuing ambitious basic and early-stage translational research to answer fundamental questions in cancer biology and underpin therapeutic development.
Funder: Cancer Research UK
Due Dates (Anticipated): January 2027 (Full application) | April 2027 (Outline) | June 2027 (Full application) | September 2027 (Outline)
Funding Amounts: Up to £2.5 million for up to five years
Summary: Long-term support for established researchers pursuing ambitious programmes addressing fundamental questions in cancer biology and early-stage translation.
Key Information: This is a closed scheme: contact discovery@cancer.org.uk at least one month before the submission deadline.
Cancer Research UK’s Discovery Programme Award supports established researchers pursuing ambitious, creative programmes in basic and early-stage translational cancer research. Each programme should have an overarching vision explored through connected aims and interrelated questions. Collaborative teams and multidisciplinary approaches are encouraged, spanning molecular mechanisms, cellular behaviour and cancer at the whole-body scale.
Overseen by the Discovery Research Committee, the scheme funds basic cancer biology, disease-specific research and preclinical studies generating biological data to underpin therapeutic development. It also supports novel technologies and methodologies, including imaging and radiotherapy approaches, when these advance understanding of cancer. Programmes building on earlier work must develop and extend that research, with a coherent plan deliverable within the award period.